Clinical Studies on BPH
It’s very helpful for men to understand the ins and outs of medications, surgical procedures and minimally invasive therapies through clinical studies. Learn through the lens of healthcare providers.
All treatments have inherent and associated risks. The Rezūm System is intended to relieve symptoms, obstructions, and reduce prostate tissue associated with BPH. It is indicated for men ≥ 50 years of age with a prostate volume 30cm3 ≤ 80cm3. The Rezūm System is also indicated for treatment of prostate with hyperplasia of the central zone and/or a median lobe. Potential risks include but are not limited to painful urination (dysuria), blood in the urine (hematuria), blood in the semen (hematospermia), decrease in ejaculatory volume, suspected urinary tract infection (UTI), and urinary frequency, retention or urgency. You should talk with your doctor about benefits and risks before moving forward with any treatment option.
Caution: U.S. Federal law restricts this device to sale by or on the order of a physician.
Content on this web page is for Informational Purposes only and does not constitute medical advice and should not be used for medical diagnoses. Boston Scientific strongly recommends that you consult with your physician on all matters pertaining to your health or to address any clinical/medical questions.
All images are the property of Boston Scientific. All trademarks are the property of their respective owners.
Rezum.com is a website sponsored by Boston Scientific.